Fate Therapeutics
FATE
#8303
Rank
NZ$0.51 B
Marketcap
NZ$4.44
Share price
-8.83%
Change (1 day)
131.41%
Change (1 year)

Fate Therapeutics (FATE) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$0.48 Billion

According to Fate Therapeutics 's latest financial reports the company's total assets are NZ$0.48 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Fate Therapeutics - Total assets on balance sheet (from 2012 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$0.55 B-29.53%
2024-12-31NZ$0.78 B-2.38%
2023-12-31NZ$0.80 B-27.97%
2022-12-31NZ$1.11 B-17.62%
2021-12-31NZ$1.34 B56.38%
2020-12-31NZ$0.86 B92.21%
2019-12-31NZ$0.44 B41.32%
2018-12-31NZ$0.31 B114.22%
2017-12-31NZ$0.14 B8.05%
2016-12-31NZ$0.13 B38.19%
2015-12-31NZ$99.29 M52%
2014-12-31NZ$65.32 M-3.42%
2013-12-31NZ$67.63 M402.37%
2012-12-31NZ$13.46 M33.83%
2011-12-31NZ$10.06 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Becton Dickinson
BDX
NZ$87.38 B 17,741.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$5.46 B 1,015.74%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$4.93 B 907.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$8.43 B 1,621.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$3.36 B 587.24%๐Ÿ‡บ๐Ÿ‡ธ USA